Patients with antecedent history of CML with CBFB::MYH11 and BCR::ABL1 tend to carry the p210 kD fusion protein [1], whereas de novo AML carries the p190 fusion protein [1]. This evidence concerns the gene MYH11 and chronic myelogenous leukemia, BCR-ABL1 positive.